Tag: Prescription Drugs
Gilead Presents Additional Data on Efficacy of Remdesivir for COVID-19
Pharma company says there is further evidence remdesivir may reduce deaths, hasten recovery
Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
VAS score reduction greater at week 16 for addition of nemolizumab versus placebo to topical agents
Long-Acting Drug Targeting Capsid Protein Promising for HIV
Reduction of viral load seen nine days after dose; sustained plasma exposure seen for more than six months
February to March 2020 Saw Surge in Hydroxychloroquine Rx
Number of patients receiving hydroxychloroquine, chloroquine prescriptions climbed across the U.S.
Upadacitinib Beats Methotrexate in Early Rheumatoid Arthritis
Significantly better clinical, radiographic, patient-reported outcomes seen with upadacitinib
COVID-19 Antibody Cocktail Begins Late-Stage Human Trials
Trial will assess whether it can prevent infection among uninfected people in close contact with an infected person
CRC Risk Down With ACEi, Angiotensin Receptor Blocker Use
5 percent reduction in adjusted hazard ratio risk with each single year increase in drug use
Roughly 2 Million Americans Buy Prescriptions From Outside the Country
Patient education, stringent quality control measures necessary to ensure safe purchases
U.S. Grab of Only COVID-19 Treatment Outrages Health Experts
Behavior sets a dangerous precedent for attempts to share scarce treatments during the pandemic, experts warn
2005 to 2016 Saw Increase in Skeletal Muscle Relaxant Use
Office visits with prescribed SMR nearly doubled; tripling in visits for continued SMR drug therapy
